Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury
Background. Revascularization of infarcted myocardium results in release of inflammatory cytokines mediating myocardial reperfusion injury and heart failure. Blockage of inflammatory pathways dampens myocardial injury and reduces infarct size. We compared the impact of the interleukin-1 receptor ant...
Saved in:
Main Authors: | Christina Grothusen, Angelika Hagemann, Tim Attmann, Jan Braesen, Ole Broch, Jochen Cremer, Jan Schoettler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/737585 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of cytokines in myocardial ischemia and reperfusion
by: H. S. Sharma, et al.
Published: (1997-01-01) -
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010-07-01) -
Intravenous Sphingosylphosphorylcholine Protects Ischemic and Postischemic Myocardial Tissue in a Mouse Model of Myocardial Ischemia/Reperfusion Injury
by: Christine Herzog, et al.
Published: (2010-01-01) -
Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury
by: Kornela Hałucha, et al.
Published: (2021-01-01) -
Comparative Effects of Verapamil, Nicardipine, and Nitroglycerin on Myocardial Ischemia/Reperfusion Injury
by: Hitoshi Yui, et al.
Published: (2011-01-01)